Eloralintide (LY3841136), a novel amylin receptor agonist for the treatment of obesity: From discovery to clinical proof of concept. [PDF]
Briere DA +17 more
europepmc +1 more source
Do no harm: managing nausea and vomiting in GLP-1 based obesity therapies. [PDF]
Alhazmi A, le Roux CW.
europepmc +1 more source
Human amylin is a potent antimicrobial peptide that exhibits antimicrobial synergism with the amyloid beta protein. [PDF]
Vijaya Kumar DK +12 more
europepmc +1 more source
Light-Mediated Insulin and Amylin Secretion: Influence of Irradiation Parameters in Optogenetically Modified Mouse-Pancreatic β Cells. [PDF]
Maharwal N +3 more
europepmc +1 more source
Central pramlintide administration potently suppresses operant responding for sucrose and locomotor activity in male rats. [PDF]
Kern KA +5 more
europepmc +1 more source
SATB1 Exhibits a Protective Role in HAmylin-Oligomer-Induced Neuronal Damage and Cognition Decline. [PDF]
Xing Y +5 more
europepmc +1 more source
Diffusing protein binders to intrinsically disordered proteins. [PDF]
Liu C +31 more
europepmc +1 more source
Future Directions in the Medical Treatment of Obesity: A Narrative Review. [PDF]
Bassatne A, Rizo I.
europepmc +1 more source
Incretin-Related Pathology and Serum Exosome Detection in Experimental Alcohol-Related Brain Damage. [PDF]
de la Monte SM, Tong M, Yang Y.
europepmc +1 more source
Isotype-selective roles of hepatic acetyl-CoA carboxylases in a mouse model of fatty liver disease. [PDF]
Beretta M +9 more
europepmc +1 more source

